Category: Uncategorized

How existing, approved drugs are being investigated for new applications in cancer care, and how molecular profiling can help patients and clinicians identify which ones may be worth exploring. The Core Idea Drug repurposing, the investigation of existing approved medications for potential applications in cancer treatment, is an area of growing scientific interest. A range…

Why terrain and molecular data belong in the same conversation and what that means for patients and clinicians. Why This Conversation Matters Cancer treatment has historically focused on the tumour, its type, its stage, its genetic mutations. And over the past two decades, precision oncology has made extraordinary progress in mapping the molecular drivers behind…

Padman Vamadevan, MD (CMO, Astron Health) and Travis Christofferson, MS (CSO, Astron Health) delivered a featured presentation for Cancer Patient Labs on how to transform raw molecular data into practical, patient-specific treatment hypotheses. Executive Summary

In oncology, progress in early detection and novel therapies has been remarkable. Yet for many patients, life after treatment remains defined by a frustrating reality: the “watch and wait” approach. Survivorship, the crucial phase after initial treatment is often overlooked, leaving patients without proactive options to reduce recurrence or improve long-term outcomes. In a recent…

How assessment-driven, patient-centered strategies can work with standard treatments to improve tolerance, confidence, and outcomes. Executive Summary Meet the Panel The conversation was enriched by perspectives from Dale’s care team and collaborators:

Our recent Expert Q&A brought together patients, caregivers, and Dr. Padman Vamadevan for a practical discussion on how to turn molecular test results into real, near-term options without replacing standard care. Key Themes Discussed